WhiteLab Genomics secures $26M Series B led by AVP to expand AI-designed gene delivery assets and bio-assets portfolio.
Amount Raised
$26 Million
Round Type
Series B
Investors
Description
WhiteLab Genomics, a genomic medicine company, closed a $26M Series B funding round led by AVP, with participation from new investors Yaday Health and Blast Club, as well as existing shareholders Omnes Capital and Debiopharm Innovation Fund. The funding will support the validation of WhiteLab's computational gene delivery designs in living systems and expand its portfolio of bio-assets. WhiteLab uses its ALFRED AI platform to design and optimize gene delivery components including AAVs, lipid nanoparticles, and synthetic promoters for gene therapy applications. The company focuses on building and licensing validated enabling technologies rather than developing complete medicines independently.
Quick answer
WhiteLab Genomics raised $26 Million in a Series B round, dated October 6, 2026. Investors: Omnes Capital, Blast.Club, Yaday Health, Avp and Debiopharm Innovation Fund.
- How much did WhiteLab Genomics raise?
- WhiteLab Genomics raised $26 Million in a Series B round on October 6, 2026.
- Who invested in WhiteLab Genomics?
- Omnes Capital, Blast.Club, Yaday Health, Avp and Debiopharm Innovation Fund are named as investors in this round.
- What does WhiteLab Genomics do?
- WhiteLab Genomics is building a portfolio of AI-designed gene delivery assets and regulatory components for genomic medicines.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as WhiteLab Genomics that raised within 45 days of this round, from Fundz verified event records.
- VolitionRx raised $2.4M (Convertible Note) on October 27, 2026.
- Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
- seragy holding GmbH raised $13M on October 14, 2026.
- Aptadir Therapeutics raised $45M (Seed) on September 29, 2026.
- Typewriter Therapeutics raised $56M (Series A) on September 2, 2026.
- Vitri Vax raised $87M (Series C) on November 18, 2026.
Who to call at WhiteLab Genomics, and when
A new round usually means WhiteLab Genomics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day WhiteLab Genomics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at WhiteLab Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at WhiteLab Genomics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment WhiteLab Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansWhiteLab Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.